Spiderwort
Founded 2015 · 18 employees on LinkedIn · 4 known investors
Spiderwort Biotechnologies is a biotechnology company developing natural, science-based solutions with potential applications across multiple industries.
Also known as Spiderwort Biotechnologies Inc.
Founders & leadership
Spiderwort was founded in 2015 by Charles M. Cuerrier and Andrew E. Pelling.
Investors · 4
Company profile
researched Aug 2026Spiderwort Biotechnologies Inc. is a biotechnology company working on plant-derived, cellulose-based biomaterials that are engineered into scaffolds for regenerative medicine and tissue engineering applications. The company positions its proprietary biomaterial platform as a framework applicable across regenerative medicine, tissue engineering and medical aesthetics.
Two products are described as under development. CelluBridge is a cellulose-based scaffold intended to support repair and regeneration of the spinal cord, pursued as a medical device program. CelluJuve is a cellulose-based dermal filler intended to support facial tissue augmentation and rejuvenation. Both programs remain pre-commercial according to the company's own descriptions.
The company's Chief Science Officer has presented the underlying approach publicly, including a TED talk on using plant-derived cellulose (for example from asparagus) as a scaffold material in the context of spinal cord injury.
Traction
As of December 2025, the company reported a peer-reviewed publication in Scientific Reports presenting findings on neural repair and motor recovery relating to its cellulose-based platform. In August 2025 it marked ten years since founding. Both named products, CelluBridge and CelluJuve, are described as under development rather than commercially available.
Latest developments
In December 2025 the company announced a publication in Nature's Scientific Reports reporting new findings on neural repair and motor recovery that it says reinforce its cellulose-based scaffold platform. In August 2025 it published a release marking its 10-year milestone.
▸Full profile — market position, technology, go-to-market
Market position
Spiderwort Biotechnologies is a development-stage company in regenerative medicine and tissue engineering, differentiating its offering through plant-derived cellulose scaffolds rather than synthetic or animal-derived biomaterials.
Technology
The core technology is a proprietary platform based on cellulose-derived biomaterials sourced from plants, which are processed into scaffolds that provide structural support for cell growth and tissue repair. The company applies the same underlying scaffold chemistry to distinct clinical targets: a spinal cord repair scaffold (CelluBridge) and an injectable dermal filler for facial soft-tissue augmentation (CelluJuve).
Go-to-market
The company's disclosed development programs address clinical applications in spinal cord injury treatment, delivered as a medical device, and medical aesthetics via a dermal filler for facial tissue augmentation and rejuvenation.
Compiled by commissioned research from 1 cited public sources — announcements, filings, and press listed under research sources below.
Timeline · 2
launches, deals, and filingsSpiderwort Biotechnologies announced a publication in Scientific Reports reporting new findings on neural repair and motor recovery supporting its cellulose-based biomaterial platform.
The company issued a news release marking its 10-year anniversary in regenerative medicine development.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
▸Research sources · 1
primary sources listed
- Spiderwortspiderwortbio.com · web
1 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Spiderwort do?
- Spiderwort Biotechnologies develops cellulose-based biomaterial scaffolds for regenerative medicine and medical aesthetics.
- Who founded Spiderwort?
- Spiderwort was founded by Charles M. Cuerrier, Andrew E. Pelling in 2015.
- Who are Spiderwort's investors?
- Spiderwort's investors include Flucas Ventures, Horizons Ventures, Sommet AB, BoxOne Ventures.